Tesaro price target lowered to $85 from $100 at Citi

Citi analyst Robyn Karnauskas lowered her price target for Tesaro shares to $85 from $100 to reflect slowed penetration into medical oncologists and the most up-to-date market share data. The analyst sees catalysts for the stock in the “data-rich” second half of 2018 but thinks investors will have to watch and see if the changes Tesaro has implemented will increase its parp penetration. Karnauskas keeps a Buy rating on the shares.
https://bit.ly/2NtuLuS